TANFACIND.BO(TANFACIND.BO)
TANFACIND.BO
No analyst ratings available
No analyst price targets available for TANFACIND.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $9.26B | $16.02B | $19.23B |
| Low | $9.26B | $16.02B | $19.23B |
| High | $9.26B | $16.02B | $19.23B |
| EBITDA Avg | $1.58B | $3.42B | $3.91B |
| Low | $1.58B | $3.42B | $3.91B |
| High | $1.58B | $3.42B | $3.91B |
| EBIT Avg | $1.27B | $2.86B | $3.10B |
| Low | $1.27B | $2.86B | $3.10B |
| High | $1.27B | $2.86B | $3.10B |
| Net Income Avg | $924M | $2.12B | $2.29B |
| Low | $924M | $2.12B | $2.29B |
| High | $924M | $2.12B | $2.29B |
| EPS Avg | $46.30 | $106.10 | $114.90 |
| Low | $46.30 | $106.10 | $114.90 |
| High | $46.30 | $106.10 | $114.90 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |